The DOI matches its Crossref record; 36 of the 38 references it cites were found in a registry or an index.
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
Open accessAbstract
Objective: The Systemic Lupus International Collaborating Clinics (SLICC) group revised and validated the American College of Rheumatology (ACR) systemic lupus erythematosus (SLE) classification criteria in order to improve clinical relevance, meet stringent methodology requirements, and incorporate new knowledge regarding the immunology of SLE. Methods: The classification criteria were derived from a set of 702 expert‐rated patient scenarios. Recursive partitioning was used to derive an initial rule that was simplified and refined based on SLICC physician consensus. The SLICC group validated the classification criteria in a new validation sample of 690 new expert‐rated patient scenarios. Results: Seventeen criteria were identified. In the derivation set, the SLICC classification criteria resulted in fewer misclassifications compared with the current ACR classification criteria (49 versus 70; P = 0.0082) and had greater sensitivity (94% versus 86%; P < 0.0001) and equal specificity (92% versus 93%; P = 0.39). In the validation set, the SLICC classification criteria resulted in fewer misclassifications compared with the current ACR classification criteria (62 versus 74; P = 0.24) and had greater sensitivity (97% versus 83%; P < 0.0001) but lower specificity (84% versus 96%; P < 0.0001). Conclusion: The new SLICC classification criteria performed well in a large set of patient scenarios rated by experts. According to the SLICC rule for the classification of SLE, the patient must satisfy at least 4 criteria, including at least one clinical criterion and one immunologic criterion OR the patient must have biopsy‐proven lupus nephritis in the presence of antinuclear antibodies or anti–double‐stranded DNA antibodies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For detection of anti-dsDNA antibodies only limited requirements for test characteristics were defined, varying from ‘increased titer’ [16,17], ‘above laboratory reference range (except for ELISA)’ [18], to ‘>90% specificity’ [19].”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The Systemic Lupus International Collaborating Clinics (SLICC) criteria published in 2012 showed that, although highly specific, the sensitivity of the ACR classification criteria for SLE was suboptimal, especially in new-onset SLE.”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consequently, anti-dsDNA testing is an essential part of the diagnosis, classification, and management of SLE (2,3,(11)(12)(13)”
From Anti-dsDNA Testing Specificity for Systemic Lupus Erythematosus: A Systematic Review. (2022) · cites this paper as [3]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“These criteria proposed to classify only patients that have at least one immunologic criterion, overcoming SLE classification based solely on clinical manifestations.”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“Accordingly, patients without the listed autoantibodies or low complement cannot be classified as having SLE.”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“new classification criteria for SLE were issued in 2012 by the Systemic Lupus International Collaborating Clinics (SLICC)”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“The new SLICC classification criteria contain several novelties compared to the ACR criteria [18].”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“The existence of anti-dsDNA Abs in the absence of positive ANA results is thought to be a rare phenomenon that is attributed to laboratory errors [40].”
From Anti-double stranded DNA antibodies: A rational diagnostic approach in limited-resource settings (2022) · cites this paper as [40]
The cited source says what the claim attributes to it.
In the citing paper
“SLE was diagnosed and classified based on either the revised American College of Rheumatology10 or the Systemic Lupus International Collaborating Clinics classification criteria.11”
From Evaluation of different ways to identify persistent positivity of lupus anticoagulant in systemic lupus erythematosus (2020) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“SLE patients were diagnosed according to revised ACR and SLICC criteria [23, 24].”
From Antiphospholipid patterns predict risk of thrombosis in systemic lupus erythematosus (2021) · cites this paper as [23]
The cited source says what the claim attributes to it.
In the citing paper
“Since 2012, the IgA isotype of the aPL has been accepted as a laboratory criterion for SLE in the SLICC SLE Classification Criteria [23].”
From Antiphospholipid patterns predict risk of thrombosis in systemic lupus erythematosus (2021) · cites this paper as [23]
The cited source says what the claim attributes to it.
In the citing paper
“The included studies used ACR 1982 (33), ACR 1997 (13), SLICC 2012 (3), or a combination of these classification criteria to define the SLE group.”
From Anti-dsDNA Testing Specificity for Systemic Lupus Erythematosus: A Systematic Review. (2022) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Classification and Regression Trees.
Gordon, A. D., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1984) · Biometrics · doi:10.2307/2530946 · Cited by 23,867
Classification and Regression Trees.
Ryzin, J. V., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1986) · Journal of the American Statistical Association · doi:10.2307/2288003 · Cited by 21,030
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
Lawrence, R. C., Felson, D. T., Helmick, C. G., Arnold, L. M., Choi, H. K., Deyo, R. A., Gabriel, S. E., Hirsch, R., Hochberg, M. C., Hunder, G. G., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23176 · Cited by 5,599
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S. M., Prosek, J. M., Nádasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,392
Gladman, D. D., Ginzler, E. M., Goldsmith, C. H., Fortin, P. R., Liang, M. H., Sánchez‐Guerrero, J., Urowitz, M. B., Bacon, P., Bombardieri, S., Hanly, J. G., et al. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390303 · Cited by 2,589
Self-citationNavarra, S., Guzmán, R., Gallacher, A., Hall, S., Levy, R. A., Jimenez, R., Li, E. K., Thomas, M., Kim, H., Leon, M. G., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61354-2 · Cited by 2,078
Self-citationEstimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I
Helmick, C. G., Felson, D. T., Lawrence, R. C., Gabriel, S. E., Hirsch, R., Kwoh, C. K., Liang, M. H., Kremers, H. M., Mayes, M. D., Merkel, P. A., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23177 · Cited by 2,054
The classification of glomerulonephritis in systemic lupus erythematosus revisited
Weening, J. J., ON Behalf of the International Society of Nephrology and Renal Pathology Society Working Group on the Classification Oflupus Nephritis, D’Agati, V. D., Schwartz, M. M., Seshan, S. V., Alpers, C. E., Appel, G. B., Balow, J. E., Bruijn, J. A., Cook, T. H., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00443.x · Cited by 1,649
Self-citation
Flagged first, then by citations
2 of the 38 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 1,011
Pocovi-Gerardino, G., Correa‐Rodríguez, M., Callejas-Rubio, J. L., Ríos-Fernández, R., Martín-Amada, M., Cruz-Caparrós, M.-G., Rueda‐Medina, B., & Ortego‐Centeno, N. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa210 · Cited by 99
Discordance of patient and physician health status concerns in systemic lupus erythematosus
Golder, V., Ooi, J. J. Y., Antony, A. S., Ko, T., Morton, S., Kandane‐Rathnayake, R., Morand, E. F., & Hoi, A. Y.-B. (2017) · Lupus · doi:10.1177/0961203317722412 · Cited by 91
Systemic Lupus Erythematosus Research: A Bibliometric Analysis over a 50-Year Period
Koo, M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18137095 · Cited by 89
Lupus nephritis: When and how often to biopsy and what does it mean?
Moroni, G. L., Depetri, F., & Ponticelli, C. E. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.06.006 · Cited by 89
An update on diet and nutritional factors in systemic lupus erythematosus management
Aparicio‐Soto, M., Sánchéz‐Hidalgo, M., & Alarcón‐de‐la‐Lastra, C. (2017) · Nutrition Research Reviews · doi:10.1017/s0954422417000026 · Cited by 89
Carvalho, C., Marinho, A., Leal, B., Bettencourt, A., Boleixa, D., Almeida, I., Farinha, F., Costa, P., Vasconcelos, C., & da Silva, B. M. (2015) · Lupus · doi:10.1177/0961203314566636 · Cited by 88
Apostolopoulos, D., Kandane‐Rathnayake, R., Louthrenoo, W., Luo, S., Wu, Y. J., Lateef, A., Golder, V., Sockalingam, S., Navarra, S., Zamora, L. D., et al. (2019) · The Lancet Rheumatology · doi:10.1016/s2665-9913(19)30105-5 · Cited by 88
Merayo‐Chalico, J., Gómez‐Martín, D., Menendez, A., Anda, K. S.-D., & Alcocer-Varela, J. C. (2013) · QJM · doi:10.1093/qjmed/hct046 · Cited by 88
A Novel System to Categorize the Symptoms of Systemic Lupus Erythematosus
Pisetsky, D. S., Clowse, M. E. B., Criscione‐Schreiber, L. G., & Rogers, J. L. (2018) · Arthritis Care & Research · doi:10.1002/acr.23794 · Cited by 87
Mummert, E., Fritzler, M. J., Sjöwall, C., Bentow, C., & Mahler, M. (2018) · Journal of Immunological Methods · doi:10.1016/j.jim.2018.05.014 · Cited by 86
Systemic lupus erythematosus biomarkers: the challenging quest
Arriens, C., Wren, J. D., Munroe, M. E., & Mohan, C. (2016) · Rheumatology · doi:10.1093/rheumatology/kew407 · Cited by 86
Guo, G., Wang, H., Shi, X., Ye, L., Yan, K., Chen, Z., Zhang, H., Jin, Z., & Xue, X. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00430 · Cited by 87
Maggi, P., Absinta, M., Sati, P., Perrotta, G., Massacesi, L., Dachy, B., Pot, C., Meuli, R. A., Reich, D. S., Filippi, M., et al. (2019) · Multiple Sclerosis Journal · doi:10.1177/1352458519876031 · Cited by 87
Alforaih, N., Whittall-García, L. P., & Touma, Z. (2022) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfac036 · Cited by 88
Extra virgin olive oil: a key functional food for prevention of immune-inflammatory diseases
Aparicio‐Soto, M., Sánchéz‐Hidalgo, M., Rosillo, M. Á., Castejón, M. L., & Alarcón‐de‐la‐Lastra, C. (2016) · Food & Function · doi:10.1039/c6fo01094f · Cited by 85
Petri, M., Fu, W., Ranger, A. M., Allaire, N., Cullen, P. F., Magder, L. S., & Zhang, Y. (2019) · BMC Medical Genomics · doi:10.1186/s12920-018-0468-1 · Cited by 85
Self-citationHuang, C. L., Li, M., Liu, Y., Wang, Q., Guo, X., Zhao, J., Lai, J., Tian, Z., Zhao, Y., & Zeng, X. (2016) · Medicine · doi:10.1097/md.0000000000002761 · Cited by 84
Bruschi, M., Petretto, A., Santucci, L., Vaglio, A., Pratesi, F., Migliorini, P., Bertelli, R., Lavarello, C., Bartolucci, M., Candiano, G., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-44379-w · Cited by 88
Jorge, A. M., Castro, V. M., Barnado, A., Gainer, V. S., Hong, C., Cai, T., Cai, T. A., Carroll, R. J., Denny, J. C., Crofford, L. J., et al. (2019) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2019.01.002 · Cited by 83
The Significance and Management of Thrombocytopenia in Antiphospholipid Syndrome
Artım-Esen, B., Küçükkaya, R. D., & İnanç, M. (2015) · Current Rheumatology Reports · doi:10.1007/s11926-014-0494-8 · Cited by 83
Antimitochondrial Antibodies: from Bench to Bedside
Colapietro, F., Lleò, A., & Generali, E. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08904-y · Cited by 82
Lupus in Latin-American patients: lessons from the GLADEL cohort
Pons‐Estel, G., Catoggio, L. J., Cardiel, M. H., Bonfá, E., Caeiro, F., Sato, E. I., Massardo, L., Molina, J. F., Toledano, M. G., Barile-Fabris, L. A., et al. (2015) · Lupus · doi:10.1177/0961203314567753 · Cited by 82
Self-citationPinheiro, S. V. B., Dias, R. F., Fabiano, R. C. G., Araújo, S. D. A., & Silva, A. C. S. E. (2018) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2018-0097 · Cited by 81
Associates and predictors of pleurisy or pericarditis in SLE
Ryu, S., Fu, W., & Petri, M. (2017) · Lupus Science & Medicine · doi:10.1136/lupus-2017-000221 · Cited by 81
Self-citationBench to bedside review of myositis autoantibodies
Palterer, B., Vitiello, G., Carraresi, A., Giudizi, M. G., Cammelli, D., & Parronchi, P. (2018) · Clinical and Molecular Allergy · doi:10.1186/s12948-018-0084-9 · Cited by 81
Performance of cytokine models in predicting SLE activity
Ruchakorn, N., Ngamjanyaporn, P., Suangtamai, T., Kafaksom, T., Polpanumas, C., Petpisit, V., Pisitkun, T., & Pisitkun, P. (2019) · Arthritis Research & Therapy · doi:10.1186/s13075-019-2029-1 · Cited by 80
Pregnancy outcome predictors in systemic lupus erythematosus: a systematic review and meta-analysis
Wind, M., Fierro, J. J., Bloemenkamp, K. W. M., de Leeuw, K., Lely, A. T., Limper, M., Sueters, M., Teng, Y. K. O., Walter, I. J., & Kooiman, J. (2024) · The Lancet Rheumatology · doi:10.1016/s2665-9913(24)00160-7 · Cited by 81
Choosing wisely: Review and commentary on anti-nuclear antibody (ANA) testing
Fritzler, M. J. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.12.002 · Cited by 80
Early symptoms of systemic lupus erythematosus (SLE) recalled by 339 SLE patients
Leuchten, N., Milke, B., Winkler-Rohlfing, B., Daikh, D., Dörner, T., Johnson, S. R., & Aringer, M. (2018) · Lupus · doi:10.1177/0961203318776093 · Cited by 80
Zhang, T., Li, H., Vanarsa, K., Gidley, G., Mok, C. C., Petri, M., Saxena, R., & Mohan, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00671 · Cited by 79
Self-citationJesús, D., Larosa, M., Henriques, C., Matos, A. C., Zen, M., Tomé, P., Alves, V. N. N., Costa, N., Guern, V. L., Iaccarino, L., et al. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-220363 · Cited by 80
Conti, F., Fulvia, C., Perricone, C., Massaro, L., Marocchi, E., Francesca, M., Spinelli, F. R., Truglia, S., Alessandri, C., & Valesini, G. (2015) · Mediators of Inflammation · doi:10.1155/2015/328078 · Cited by 79
Mohan, C., & Assassi, S. (2015) · BMJ · doi:10.1136/bmj.h5079 · Cited by 78
Rutter‐Locher, Z., Smith, T. O., Giles, I., & Sofat, N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01295 · Cited by 78
Qian, J., Li, M., Zhang, X., Wang, Q., Zhao, J., Tian, Z., Wei, W., Zuo, X., Zhang, M., Zhu, P., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.00081-2018 · Cited by 78
Glomerular Hematuria and the Utility of Urine Microscopy: A Review
Saha, M. K., Massicotte‐Azarniouch, D., Reynolds, M. L., Mottl, A. K., Falk, R. J., Jennette, J. C., & Derebail, V. K. (2022) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2022.02.022 · Cited by 78
Putterman, C., Furie, R. A., Ramsey‐Goldman, R., Askanase, A., Buyon, J. P., KALUNIAN, K. C., Chatham, W. W., Massarotti, E. M., Kirou, K. A., Jordan, N., et al. (2014) · Lupus Science & Medicine · doi:10.1136/lupus-2014-000056 · Cited by 78
Self-citationCrampton, S. P., Morawski, P. A., & Bolland, S. M. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.016451 · Cited by 78
Broder, A. R., Mowrey, W. B., Khan, H., Jovanovic, B., Jimenez, A. L., Izmirly, P., & Putterman, C. (2017) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2017.07.007 · Cited by 78
Fanouriakis, A., Adamichou, C., Koutsoviti, S., Panopoulos, S., Staveri, C., Klagou, A., Tsalapaki, C., Pantazi, L., Konsta, S., Mavragani, C. P., et al. (2018) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2018.02.014 · Cited by 78
Barraclough, M. L., McKie, S., Parker, B., Jackson, A., Pemberton, P. W., Elliott, R., & Bruce, I. N. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-214677 · Cited by 78
Self-citationFonseca, A. R., Rodrigues, M. C. F., Sztajnbok, F., Land, M. G. P., & de Oliveira, S. K. F. (2019) · Revista Brasileira de Reumatologia · doi:10.1186/s42358-019-0062-z · Cited by 77
Mok, C. C., Hamijoyo, L., Kasitanon, N., Chen, D. Y., Chen, S., Yamaoka, K., Oku, K., Li, M. T., Zamora, L. D., Bae, S., et al. (2021) · The Lancet Rheumatology · doi:10.1016/s2665-9913(21)00009-6 · Cited by 77
Self-citationThe global epidemiology of SLE: narrowing the knowledge gaps
Barber, M. R. W., Falasinnu, T., Ramsey‐Goldman, R., & Clarke, A. E. (2022) · Rheumatology · doi:10.1093/rheumatology/keac610 · Cited by 77
Self-citationSjöwall, C., Zapf, J., von Löhneysen, S., Magorivska, I., Biermann, M. H. C., Janko, C., Winkler, S., Bilyy, R. O., Schett, G. A., i, M. H., et al. (2014) · Lupus · doi:10.1177/0961203314558861 · Cited by 77
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease
Ferri, C., Manfredi, A., Sebastiani, M., Colaci, M., Giuggioli, D., Vacchi, C., Casa, G. D., Cerri, S., Torricelli, P., & Luppi, F. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.09.003 · Cited by 77
Manfredi, A., Sebastiani, M., Cerri, S., Cassone, G., Bellini, P., Casa, G. D., Luppi, F., & Ferri, C. (2017) · Clinical Rheumatology · doi:10.1007/s10067-017-3601-1 · Cited by 77
Hanly, J. G., Li, Q., Su, L., Urowitz, M. B., Gordon, C., Bae, S., Romero‐Díaz, J., Sánchez‐Guerrero, J., Bernatsky, S., Clarke, A. E., et al. (2018) · Arthritis Care & Research · doi:10.1002/acr.23509 · Cited by 77
Self-citationÁlvarez‐Rodríguez, L., Martínez-Taboada, V. M., Alén, J. C., Beares, I., Villa, I., & López‐Hoyos, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00391 · Cited by 79
Hanly, J. G., Li, Q., Su, L., Urowitz, M. B., Gordon, C., Bae, S., Romero‐Díaz, J., Sánchez‐Guerrero, J., Bernatsky, S., Clarke, A. E., et al. (2019) · Arthritis & Rheumatology · doi:10.1002/art.41070 · Cited by 76
Self-citationCheng, R., Xiong, A., Li, Y., Pan, S.-Y., Zhang, Q., Zhao, Y., Liu, Y. F., & Marion, T. N. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00285 · Cited by 76
Recognition and control of neutrophil extracellular trap formation by MICL
Malamud, M., Whitehead, L., McIntosh, A., Colella, F., Roelofs, A. J., Kusakabe, T., Dambuza, I. M., Phillips-Brookes, A., Salazar, F., Perez, F., et al. (2024) · Nature · doi:10.1038/s41586-024-07820-3 · Cited by 77
Mucocutaneous manifestations in juvenile-onset systemic lupus erythematosus: a review of literature
Chiewchengchol, D., Murphy, R., Edwards, S. W., & Beresford, M. W. (2015) · Pediatric Rheumatology · doi:10.1186/1546-0096-13-1 · Cited by 76
TLR4+CXCR4+ plasma cells drive nephritis development in systemic lupus erythematosus
Ma, K., Li, J., Wang, X., Lin, X., Du, W., Yang, X., Mou, F., Fang, Y., YanBin, Z., Hong, X., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-213615 · Cited by 76
Alopecias in lupus erythematosus
Concha, J. S. S., & Werth, V. P. (2018) · Lupus Science & Medicine · doi:10.1136/lupus-2018-000291 · Cited by 76
Self-citationANA as an entry criterion for the classification of SLE
Pisetsky, D. S., Bossuyt, X., & Meroni, P. L. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.102400 · Cited by 78
Sjögren's syndrome: Where do we stand, and where shall we go?
Cornec, D., Jamin, C., & Pers, J. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.02.006 · Cited by 75
for the Swiss Systemic Lupus Erythematosus Cohort Study Group, Chaigne, B., Chizzolini, C., Perneger, T., Trendelenburg, M., Huynh‐Do, U., Dayer, E., Stoll, T. M., von Kempis, J., & Ribi, C. (2017) · BMC Immunology · doi:10.1186/s12865-017-0200-5 · Cited by 75
Self-citationFloris, A., Piga, M., Cauli, A., & Mathieu, A. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.02.019 · Cited by 74
Zhu, H., Hu, F., Sun, X., Zhang, X., Zhu, L., Liu, X., Li, X., Xu, L., Shi, L., Gan, Y., et al. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00512 · Cited by 74
Liu, T., Gu, J., Wan, L., Hu, Q., Teng, J., Liu, H., Cheng, X., Ye, J., Su, Y., Sun, Y., et al. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-2131-4 · Cited by 74
Davidson, J. E., Fu, Q., Ji, B., Rao, S., Roth, D. A., Magder, L. S., & Petri, M. (2018) · The Journal of Rheumatology · doi:10.3899/jrheum.161554 · Cited by 74
Self-citationPark, E. H., Strand, V., Oh, Y. J., Song, Y. W., & Lee, E. B. (2019) · Arthritis Research & Therapy · doi:10.1186/s13075-019-1842-x · Cited by 74
Enocsson, H., Sjöwall, C., Wirestam, L., Dahle, C., Kastbom, A., Rönnelid, J., Wetterö, J., & Skogh, T. (2015) · The Journal of Rheumatology · doi:10.3899/jrheum.140677 · Cited by 73
Deconstructing the sex bias in allergy and autoimmunity: From sex hormones and beyond
Laffont, S., & Guéry, J. (2019) · Advances in immunology · doi:10.1016/bs.ai.2019.04.001 · Cited by 76
Merrill, J. T., Tanaka, Y., D’Cruz, D. P., Vilá-Rivera, K., Siri, D., Zeng, X., Saxena, A., Aringer, M., D’Silva, K. M., Cheng, L., et al. (2024) · Arthritis & Rheumatology · doi:10.1002/art.42926 · Cited by 73
Self-citationFitch-Rogalsky, C., Steber, W. A., Mähler, M., Lupton, T. L., Martin, L. O., Barr, S. G., Mosher, D. P., Wick, J., & Fritzler, M. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093812 · Cited by 73
Kikuchi-Fujimoto disease and systemic lupus erythematosus
Baenas, D. F., Diehl, F., Salinas, M. J. H., Riva, V., Diller, A., & Lemos, P. (2016) · International Medical Case Reports Journal · doi:10.2147/imcrj.s106396 · Cited by 73
Ciancio, N., Pavone, M., Torrisi, S. E., Vancheri, A., Sambataro, D., Palmucci, S., Vancheri, C., Marco, F. D., & Sambataro, G. (2019) · Multidisciplinary Respiratory Medicine · doi:10.1186/s40248-019-0179-2 · Cited by 73
Tedeschi, S. K., Johnson, S. R., Boumpas, D. T., Daikh, D., Dörner, T., Diamond, B., Jacobsen, S., Jayne, D. R. W., Kamen, D. L., McCune, W. J., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-214685 · Cited by 72
Self-citationCostedoat-Chalumeau, N., Houssiau, F., Izmirly, P., Guern, V. L., Navarra, S., Jolly, M., Ruiz‐Irastorza, G., Baron, G., HACHULLA, E., Agmon‐Levin, N., et al. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.885 · Cited by 72
Self-citationMortality and prognostic factors in Chinese patients with systemic lupus erythematosus
Mu, L., Hao, Y., Fan, Y., Huang, H., Yang, X., Xie, A., Zhang, X., Ji, L., Geng, Y., & Zhang, Z. (2018) · Lupus · doi:10.1177/0961203318789788 · Cited by 72
Sambataro, G., Sambataro, D., Torrisi, S. E., Vancheri, A., Colaci, M., Pavone, M., Pignataro, F. S., Papa, N. D., Palmucci, S., & Vancheri, C. (2019) · Respiratory Medicine · doi:10.1016/j.rmed.2019.03.011 · Cited by 72
Sensitivity and Specificity of Pathologic Findings to Diagnose Lupus Nephritis
Kudose, S., Santoriello, D., Bomback, A. S., Stokes, M. B., D’Agati, V. D., & Markowitz, G. S. (2019) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01570219 · Cited by 72
Gergianaki, I., & Bertsias, G. K. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00161 · Cited by 74
Type 1 interferon status in systemic lupus erythematosus: a longitudinal analysis
Northcott, M., Jones, S. A., Koelmeyer, R., Bonin, J., Vincent, F. B., Kandane‐Rathnayake, R., Hoi, A. Y.-B., & Morand, E. F. (2022) · Lupus Science & Medicine · doi:10.1136/lupus-2021-000625 · Cited by 71
High-throughput identification of autoantibodies that target the human exoproteome
Wang, E. Y., Dai, Y., Rosen, C. E., Schmitt, M. M., Dong, M. X., Ferré, E. M. N., Liu, F., Yang, Y., González-Hernández, J. A., Meffre, E., et al. (2022) · Cell Reports Methods · doi:10.1016/j.crmeth.2022.100172 · Cited by 76
Autoimmune Diseases: Molecular Pathogenesis and Therapeutic Targets
Song, X., Liang, H., Nan, F., Chen, W., Li, J., Liu, H., Cun, Y., Li, Z., Zhang, W., & Zhang, D. (2025) · MedComm · doi:10.1002/mco2.70262 · Cited by 72
Infections and Systemic Lupus Erythematosus: Binding or Sparring Partners?
Rigante, D., & Esposito, S. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160817331 · Cited by 71
Ball, E., Gibson, D. S., Bell, A., & Rooney, M. (2013) · Lupus · doi:10.1177/0961203313512882 · Cited by 71
Chasset, F., Arnaud, L., Costedoat-Chalumeau, N., Zahr, N., Bessis, D., & Francès, C. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.09.064 · Cited by 71
Jabs, D. A., Dick, A. D., Doucette, J. T., Gupta, A., Lightman, S., McCluskey, P., Okada, A. A., Palestine, A. G., Rosenbaum, J. T., Saleem, S., et al. (2017) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2017.10.028 · Cited by 70
Lupus community panel proposals for optimising clinical trials: 2018
Merrill, J. T., Manzi, S., Aranow, C. B., Askenase, A., Bruce, I. N., Chakravarty, E. F., Chong, B., Costenbader, K. H., Dall’Era, M., Ginzler, E. M., et al. (2018) · Lupus Science & Medicine · doi:10.1136/lupus-2018-000258 · Cited by 70
Self-citationKudela, H., Drynda, S., Lux, A., Horneff, G., & Kekow, J. (2019) · BMC Rheumatology · doi:10.1186/s41927-019-0053-z · Cited by 70
Kameda, M., Otsuka, M., Chiba, H., Kuronuma, K., Hasegawa, T., Takahashi, H., & Takahashi, H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241719 · Cited by 70
Platelet CXCL4 mediates neutrophil extracellular traps formation in ANCA-associated vasculitis
Matsumoto, K., Yasuoka, H., Yoshimoto, K., Suzuki, K., & Takeuchi, T. (2021) · Scientific Reports · doi:10.1038/s41598-020-80685-4 · Cited by 70
Genetics and novel aspects of therapies in systemic lupus erythematosus
Relle, M., Weinmann‐Menke, J., Scorletti, E., Cavagna, L., & Schwarting, A. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.07.003 · Cited by 73
Structure and Function of Renal Macrophages and Dendritic Cells From Lupus‐Prone Mice
Sahu, R. K., Bethunaickan, R., Singh, S., & Davidson, A. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38410 · Cited by 70
Pons‐Estel, G., WOJDYLA, D. M., McGwin, G., Magder, L. S., Petri, M., Pons‐Estel, B. A., (GLADEL), O. B. O. T. G. L. D. E. D. L. E., Alarcón, G., & cohort, O. B. O. T. L. (2013) · Lupus · doi:10.1177/0961203313512883 · Cited by 70
Self-citationDima, A., Jurcuț, C., & Băicuş, C. (2018) · Rheumatology International · doi:10.1007/s00296-018-4059-4 · Cited by 70
“Better explanations” in multiple sclerosis diagnostic workup: A 3-year longitudinal study
Calabrese, M., Gasperini, C., Tortorella, C., Schiavi, G., Frisullo, G., Ragonese, P., Fantozzi, R., Prosperini, L., Annovazzi, P., Cordioli, C., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000007573 · Cited by 70
Aringer, M., Leuchten, N., & Johnson, S. R. (2020) · Current Rheumatology Reports · doi:10.1007/s11926-020-00896-6 · Cited by 73
High Comorbidity Burden in Patients with SLE: Data from the Community-Based Lupus Registry of Crete
Gergianaki, I., Garantziotis, P., Adamichou, C., Saridakis, I., Spyrou, G., Sidiropoulos, P. I., & Bertsias, G. K. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10050998 · Cited by 69
Lee, H.-T., Lin, C.-S., Lee, C.-S., Tsai, C.-Y., & Wei, Y.-H. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12256 · Cited by 71
Aringer, M., Brinks, R., Dörner, T., Daikh, D., Mosca, M., Ramsey-Goldman, R., Smolen, J. S., Wofsy, D., Boumpas, D. T., Kamen, D. L., et al. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-219373 · Cited by 68
Self-citationCorrea‐Rodríguez, M., Pocovi-Gerardino, G., Callejas-Rubio, J. L., Ríos-Fernández, R., Martín-Amada, M., Cruz-Caparrós, M.-G., Ortego‐Centeno, N., & Rueda‐Medina, B. (2019) · Nutrients · doi:10.3390/nu11030638 · Cited by 68
Chaudhary, V., Kioon, M. D. A., Hwang, S., Mishra, B., Lakin, K. S., Kirou, K. A., Zhang-Sun, J., Wiseman, R. L., Spiera, R., Crow, M. K., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20221085 · Cited by 69
Comparison between three systems of classification criteria in juvenile systemic lupus erythematous
Fonseca, A. R., Elsas, M., Land, M. G. P., & de Oliveira, S. K. F. (2014) · Rheumatology · doi:10.1093/rheumatology/keu278 · Cited by 68
Frodlund, M., Dahlström, Ö., Kastbom, A., Skogh, T., & Sjöwall, C. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003608 · Cited by 68
Selmi, C. F., Ceribelli, A., Generali, E., Scirè, C. A., Alborghetti, F., Colloredo, G., Porrati, L., Achenza, M. I. S., Santis, M. D., Cavaciocchi, F., et al. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.10.007 · Cited by 68
Metadata
- Authors
- Petri, M., Orbai, A., Alarcón, G. S., Gordon, C., Merrill, J. T., Fortin, P. R., Bruce, I. N., Isenberg, D., Wallace, D. J., Nived, O., Sturfelt, G., Ramsey‐Goldman, R., Bae, S., Hanly, J. G., Sánchez‐Guerrero, J., Clarke, A., Aranow, C., Manzi, S., Urowitz, M., Gladman, D., Kalunian, K., Costner, M., Werth, V. P., Zoma, A., Bernatsky, S., Ruiz‐Irastorza, G., Khamashta, M. A., Jacobsen, S., Buyon, J. P., Maddison, P., Dooley, M. A., van Vollenhoven, R. F., Ginzler, E., Stoll, T., Peschken, C., Jorizzo, J. L., Callen, J. P., Lim, S. S., Fessler, B. J., Inanc, M., Kamen, D. L., Rahman, A., Steinsson, K., Franks, A. G., Sigler, L., Hameed, S., Fang, H., Pham, N., Brey, R., Weisman, M. H., McGwin, G., & Magder, L. S.
- Affiliations
- Johns Hopkins University (US)
- University of Alabama at Birmingham (US)
- University of Birmingham (GB)
- Oklahoma Medical Research Foundation (US)
- Centre hospitalier universitaire de Québec (CA)
- Manchester Academic Health Science Centre (GB)
- Cedars-Sinai Medical Center (US)
- Skåne University Hospital (SE)
- Northwestern University (US)
- Dalhousie University (CA)
- Mount Sinai Hospital (CA)
- Feinstein Institute for Medical Research (US)
- Toronto Western Hospital (CA)
- University of California San Diego (US)
- University of Pennsylvania (US)
- Hairmyres Hospital (GB)
- McGill University Health Centre (CA)
- University of the Basque Country (ES)
- St Thomas' Hospital (GB)
- New York University (US)
- Ysbyty Gwynedd Hospital NHS Trust (GB)
- University of North Carolina at Chapel Hill (US)
- Karolinska University Hospital (SE)
- SUNY Downstate Health Sciences University (US)
- Spitäler Schaffhausen (CH)
- Atrium Health Wake Forest Baptist (US)
- University of Louisville (US)
- Emory University (US)
- Medical University of South Carolina (US)
- University of Maryland, Baltimore (US)
- Corresponding author
- Petri, Michelle
- ORCID
- Petri, Michelle
- Orbai, Ana‐Maria
- Alarcón, Graciela S.
- Gordon, Caroline
- Merrill, Joan T.
- Fortin, Paul R.
- Bruce, Ian N.
- Isenberg, David
- Wallace, Daniel J.
- Nived, Ola
- Ramsey‐Goldman, Rosalind
- Bae, Sang‐Cheol
- Hanly, John G.
- Sánchez‐Guerrero, Jorge
- Clarke, Ann
- Aranow, Cynthia
- Manzi, Susan
- Urowitz, Murray
- Gladman, Dafna
- Kalunian, Kenneth
- Werth, Victoria P.
- Bernatsky, Sasha
- Ruiz‐Irastorza, Guillermo
- Khamashta, Munther A.
- Buyon, Jill P.
- Maddison, Peter
- Ginzler, Ellen
- Stoll, Thomas
- Peschken, Christine
- Jorizzo, Joseph L.
- Callen, Jeffrey P.
- Lim, S. Sam
- Kamen, Diane L.
- Rahman, Anisur
- Franks, Andrew G.
- Fang, Hong
- Brey, Robin
- Weisman, Michael H.
- McGwin, Gerald
- Magder, Laurence S.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2012-07-27
- Volume
- 64
- Issue
- 8
- Pages
- 2677-2686
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- PMC
- PMC3409311
- OpenAlex
- W2159860161
- Cited by
- 5,322
- References
- 38
- Citations by year
- 2026: 322 · 2025: 421 · 2024: 454 · 2023: 507 · 2022: 550 · 2021: 572 · 2020: 524 · 2019: 450 · 2018: 415 · 2017: 343 · 2016: 282 · 2015: 220 · 2014: 163 · 2013: 78 · 2012: 13
- FWCI
- 116.60
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Arthritis & Rheumatism (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- SUNY Digital Repository Support (State University of New York System) (submittedVersion, cc-by-nc-nd)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Hirsla (Landspítali University Hospital) (submittedVersion)
- Funders
- National Institutes of Health (UL1TR000150)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR043727, U01AR051871, T32AR048522)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Keywords
- systemic lupus erythematosus, classification criteria, SLICC criteria, ACR classification criteria, diagnostic accuracy, sensitivity and specificity, recursive partitioning, lupus nephritis, antinuclear antibodies, anti-dsDNA antibodies
- MeSH terms
- Antibodies, Anti-Idiotypic, Antibodies, Antinuclear, Biopsy, DNA, Humans, International Agencies, Lupus Erythematosus, Systemic, Lupus Nephritis, Sensitivity and Specificity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
